Centenial Surgical Suture (BOM:531380) Cyclically Adjusted Revenue per Share: ₹175.34 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531380 Centenial Surgical Suture Ltd BOM:531380
60 GF Score
Price ₹97.50
GF Value ₹110.47
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Centenial Surgical Suture Cyclically Adjusted Revenue per Share?

Centenial Surgical Suture BOM:531380 +3.72% 60 Cyclically Adjusted Revenue per Share is ₹175.34 as of Mar. 2026. GuruFocus rates BOM:531380 with a GF Score™ of 60/100 and a GF Value™ of ₹110.47 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Centenial Surgical Suture's adjusted revenue per share for the three months ended in Mar. 2026 was ₹34.489. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹175.34 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Centenial Surgical Suture's average Cyclically Adjusted Revenue Growth Rate was -0.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -1.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Centenial Surgical Suture was -1.00% per year. The lowest was -1.20% per year. And the median was -1.10% per year.

As of today (2026-08-24), Centenial Surgical Suture's current stock price is ₹97.50. Centenial Surgical Suture's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₹175.34. Centenial Surgical Suture's Cyclically Adjusted PS Ratio of today is 0.56.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Centenial Surgical Suture was 0.94. The lowest was 0.19. And the median was 0.44.


Centenial Surgical Suture  (BOM:531380) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Centenial Surgical Suture's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=97.50/175.34
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Centenial Surgical Suture was 0.94. The lowest was 0.19. And the median was 0.44.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Centenial Surgical Suture Cyclically Adjusted Revenue per Share Related Terms


Centenial Surgical Suture Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Centenial Surgical Suture's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Centenial Surgical Suture Cyclically Adjusted Revenue per Share Chart

Centenial Surgical Suture Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 182.18 181.02 179.17 175.90 175.34

Centenial Surgical Suture Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 175.90 176.05 176.77 176.20 175.34

BOM:531380 vs ISRG, BDX, MDLN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Centenial Surgical Suture's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centenial Surgical Suture Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Centenial Surgical Suture's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Centenial Surgical Suture's Cyclically Adjusted PS Ratio falls into.


BOM:531380
60GF Score
Centenial Surgical Suture Ltd BOM:531380
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Centenial Surgical Suture Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Centenial Surgical Suture's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=34.489/164.2724*164.2724
=34.489

Current CPI (Mar. 2026) = 164.2724.

Centenial Surgical Suture Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 39.916 105.961 61.882
201609 33.729 105.961 52.290
201612 35.535 105.196 55.491
201703 34.452 105.196 53.800
201706 41.385 107.109 63.472
201709 34.941 109.021 52.649
201712 37.194 109.404 55.848
201803 31.177 109.786 46.650
201806 40.192 111.317 59.312
201809 38.821 115.142 55.386
201812 36.958 115.142 52.728
201903 37.360 118.202 51.921
201906 39.236 120.880 53.321
201909 38.859 123.175 51.824
201912 36.102 126.235 46.980
202003 38.223 124.705 50.351
202006 16.405 127.000 21.220
202009 22.304 130.118 28.159
202012 22.384 130.889 28.093
202103 40.187 131.771 50.099
202106 23.290 134.084 28.534
202109 32.763 135.847 39.619
202112 33.738 138.161 40.114
202203 32.131 138.822 38.022
202206 37.066 142.347 42.775
202209 35.583 144.661 40.407
202212 35.821 145.763 40.370
202303 35.853 146.865 40.103
202306 37.463 150.280 40.951
202309 36.028 151.492 39.067
202312 33.948 152.924 36.467
202403 33.167 153.035 35.603
202406 37.771 155.789 39.828
202409 39.459 157.882 41.056
202412 33.095 158.323 34.339
202503 36.430 157.552 37.984
202506 36.388 159.755 37.417
202509 33.638 162.289 34.049
202512 40.447 163.281 40.693
202603 34.489 164.272 34.489

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹175.34 mean?
Centenial Surgical Suture (BOM:531380) has a Cyclically Adjusted Revenue per Share of ₹175.34 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Centenial Surgical Suture and its competitors.
Is Centenial Surgical Suture's Cyclically Adjusted Revenue per Share too high?
Centenial Surgical Suture's current Cyclically Adjusted Revenue per Share is ₹175.34. Overall, Centenial Surgical Suture has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Centenial Surgical Suture's Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
Centenial Surgical Suture's Cyclically Adjusted Revenue per Share of ₹175.34 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Centenial Surgical Suture and its competitors. Centenial Surgical Suture's current Cyclically Adjusted Revenue per Share is ₹175.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centenial Surgical Suture stock overvalued right now?
Based on GuruFocus' analysis, Centenial Surgical Suture (BOM:531380) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹110.47, compared to a current price of ₹97.50 — trading 11.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹175.34. Centenial Surgical Suture's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Centenial Surgical Suture (BOM:531380), the current Cyclically Adjusted Revenue per Share is ₹175.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Centenial Surgical Suture (BOM:531380) Overvalued in 2026?

Based on GuruFocus' analysis, Centenial Surgical Suture stock appears to be undervalued. The current stock price of ₹97.50 is trading 11.7% below its estimated GF Value™ of ₹110.47. GuruFocus considers Centenial Surgical Suture to be Modestly Undervalued.

Key valuation signals for BOM:531380:

  • Cyclically Adjusted Revenue per Share: ₹175.34
  • GF Value™: ₹110.47 vs. price of ₹97.50 (11.7% below fair value)
  • GF Score™: 60/100 with 5 warning signs

No single metric tells the full story. See the BOM:531380 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Centenial Surgical Suture Business Description

Address F-29, MIDC, Murbad, Thane, MH, IND, 421401
Centenial Surgical Suture Ltd is an India-based company engaged in manufacturing, marketing, and selling quality atraumatic needles and sutures; absorbable-synthetic; and other medical devices approved and licensed by Food and Drug Administration (FDA). The company's only segment is the manufacturing and sale of Medical Devices. The company sells its products in India and also exports internationally, generating a vast majority of the revenue within India.
60GF Score

Get the complete analysis for BOM:531380

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹97.50
Price
₹110.47
GF Value